ACCELERATEIQ Trademark

Trademark Overview

On Tuesday, March 13, 2018, a trademark application was filed for ACCELERATEIQ with the United States Patent and Trademark Office. The USPTO has given the ACCELERATEIQ trademark a serial number of 87832192. The federal status of this trademark filing is REGISTERED as of Tuesday, June 9, 2020. This trademark is owned by PhysIQ, Inc.. The ACCELERATEIQ trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
accelerateiq

General Information

Serial Number87832192
Word MarkACCELERATEIQ
Filing DateTuesday, March 13, 2018
Status700 - REGISTERED
Status DateTuesday, June 9, 2020
Registration Number6075458
Registration DateTuesday, June 9, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 31, 2018

Trademark Statements

Pseudo MarkACCELERATE IQ
Goods and ServicesProviding medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 20, 2018
Primary Code042
First Use Anywhere DateMonday, March 5, 2018
First Use In Commerce DateMonday, March 5, 2018

Trademark Owner History

Party NamePROLAIO, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSCOTTSDALE, AZ 85250
Party NamePhysIQ, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNaperville, IL 60563
Party NamePhysIQ, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNaperville, IL 60563
Party NamePhysIQ, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNaperville, IL 60563

Trademark Events

Event DateEvent Description
Tuesday, March 5, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 5, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 5, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 5, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 5, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, January 10, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, June 9, 2020REGISTERED-PRINCIPAL REGISTER
Friday, May 8, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, May 7, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, December 4, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 3, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 3, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 3, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 3, 2019NON-FINAL ACTION E-MAILED
Monday, June 3, 2019SU - NON-FINAL ACTION - WRITTEN
Tuesday, April 23, 2019STATEMENT OF USE PROCESSING COMPLETE
Tuesday, April 9, 2019USE AMENDMENT FILED
Sunday, April 21, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 9, 2019TEAS STATEMENT OF USE RECEIVED
Wednesday, March 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 25, 2019SOU EXTENSION 1 GRANTED
Monday, March 25, 2019SOU EXTENSION 1 FILED
Monday, March 25, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, September 25, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 31, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 31, 2018PUBLISHED FOR OPPOSITION
Wednesday, July 11, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 26, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, June 24, 2018ASSIGNED TO EXAMINER
Tuesday, March 20, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 16, 2018NEW APPLICATION ENTERED

Related Keywords

accelerateiq pharmaceuticals clinical trials field information medical scientific research providing